Sunshine Biopharma Inc (MWBN) financial statements (2021 and earlier)

Company profile

Business Address 6500 TRANS-CANADA HIGHWAY
POINTE-CLAIRE, QC H9R 0A5
State of Incorp. CO
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments990411151085751143
Cash and cash equivalents990411151085751143
Receivables2095    
Other undisclosed current assets342511013 
Total current assets:1,026662121175854143
Noncurrent Assets
Property, plant and equipment20322696064 
Intangible assets, net (including goodwill)  666  615 
Goodwill  666 (556)  
Intangible assets, net (excluding goodwill)    556615 
Deposits noncurrent assets   80   
Total noncurrent assets:20329351406619 
TOTAL ASSETS:1,045981,14725764673143
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8711820029374951
Accounts payable639719119284735
Interest and dividends payable2421999316
Debt82058642051770305480
Due to related parties14412949206167916 
Other undisclosed current liabilities  243    
Total current liabilities:1,0518349127512741,270531
Noncurrent Liabilities
Long-term debt and lease obligation949 29080   
Long-term debt, excluding current maturities949 29080   
Total noncurrent liabilities:949 29080   
Total liabilities:2,0008341,2028312741,270531
Stockholders' equity
Stockholders' equity attributable to parent, including:(955)(735)(56)(573)(210)(597)(388)
Common stock346358691976919874
Additional paid in capital18,82016,61615,58712,07611,5488,2356,967
Accumulated other comprehensive income (loss)(3)(2)(4)101 
Accumulated deficit(20,219)(17,435)(15,774)(13,618)(12,578)(9,081)(7,428)
Other undisclosed stockholders' equity attributable to parent1005050505050 
Total stockholders' equity:(955)(735)(56)(573)(210)(597)(388)
TOTAL LIABILITIES AND EQUITY:1,045981,14725764673143

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues7121447  2 
Revenue, net  2 
Cost of revenue(26)(11)(391) (19)(385)(263)
Cost of goods and services sold    (19)(385)(263)
Gross profit:461056 (19)(383)(263)
Operating expenses(622)(652)(1,223)(857)(993)(782)(2,465)
Other undisclosed operating income    19385973
Operating loss:(577)(642)(1,167)(857)(993)(780)(1,755)
Nonoperating expense(2,207)(436)(990)(183)(2,504)(873)(179)
Interest and debt expense(2,226)(315)(872)(77)(1,946)(575)(179)
Loss from continuing operations:(5,010)(1,393)(3,028)(1,117)(5,443)(2,228)(2,113)
Loss from discontinued operations (582)     
Loss before gain (loss) on sale of properties:(5,010)(1,975)(3,028)(1,117)(5,443)(2,228)(2,113)
Other undisclosed net income2,226315867771,946576 
Net loss:(2,784)(1,660)(2,160)(1,040)(3,497)(1,652)(2,113)
Other undisclosed net income (loss) attributable to parent  4(0) (1)179
Net loss available to common stockholders, diluted:(2,784)(1,660)(2,156)(1,040)(3,497)(1,653)(1,934)

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(2,784)(1,660)(2,160)(1,040)(3,497)(1,652)(2,113)
Other comprehensive income (loss)01(4)0(0)1 
Comprehensive loss:(2,784)(1,659)(2,165)(1,040)(3,497)(1,651)(2,113)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  4(0) (1) 
Comprehensive loss, net of tax, attributable to parent:(2,784)(1,659)(2,160)(1,040)(3,497)(1,652)(2,113)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: